MAGGI, CLAUDIA

MAGGI, CLAUDIA  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 20 di 24 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Activity of temozolomide in patients with advanced chemorefractory colorectal cancer and MGMT promoter methylation 1-feb-2014 F. PietrantonioF. PerroneF. De BraudC. MaggiGEVORGYAN, ARPINEP. BiondaniF. Festinese + Article (author) -
Bevacizumab treatment in the elderly patient with metastatic colorectal cancer 1-gen-2015 C. MaggiF. RicchiniF. PietrantonioF. de Braud + Article (author) -
Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer : an Italian Trials of Medical Oncology phase II study 1-gen-2015 F. PietrantonioK. F. DottiC. Maggi + Article (author) -
Chemotherapy or targeted therapy as second-line treatment of advanced gastric cancer. A systematic review and meta-analysis of published studies 1-set-2014 F. PietrantonioC. MaggiF. RicchiniF. De Braud + Article (author) -
Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory, RAS-BRAF wild-type colorectal cancer receiving cetuximab or panitumumab 15-set-2015 V. MusellaF. PietrantonioC. MaggiF. de Braud + Article (author) -
Combination or single-agent chemotherapy as adjuvant treatment of gastric cancer : A systematic review and meta-analysis of published trials 1-feb-2016 F. PietrantonioC. MaggiF. de Braud + Article (author) -
Dose-Dense Temozolomide in Patients with MGMT-Silenced Chemorefractory Colorectal Cancer 1-giu-2016 F. PietrantonioF. de BraudC. MaggiK.F. DottiA. Pellegrinelli + Article (author) -
DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan 1-set-2015 F.S. FalvellaS. CheliC. MazzaliC. MaggiM. Di BartolomeoI. BossiF. de BraudE. ClementiF. Pietrantonio + Article (author) -
First-line anti-EGFR monoclonal antibodies in panRAS wild-type metastatic colorectal cancer : a systematic review and meta-analysis 1-ott-2015 F. PietrantonioF. PetrelliM. Di BartolomeoC. MaggiF. de Braud + Article (author) -
FOLFOX-4 chemotherapy for patients with unresectable or relapsed peritoneal pseudomyxoma 1-ago-2014 F. PietrantonioC. MaggiG. FanettiF. RicchiniI. BossiG. PelosiF. de Braud + Article (author) -
Gain of ALK gene copy number may predict lack of benefit from anti-EGFR treatment in patients with advanced colorectal cancer and RAS-RAF-PI3KCA wild-type status 1-apr-2014 F. PietrantonioC. MaggiI. BossiG. PelosiF. De Braud + Article (author) -
GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab : A clinical and translational study 1-mag-2016 F. PietrantonioC. MaggiM. NigerA. MennittoF. de Braud + Article (author) -
In reply 1-mar-2015 C. MaggiF. DebraudF. Pietrantonio + Article (author) -
Incidence and relative risk of grade 3 and 4 diarrhoea in patients treated with capecitabine or 5-fluorouracil : a meta-analysis of published trials 1-gen-2014 F. PietrantonioC. MaggiF. RicchiniF. De Braud + Article (author) -
Pathological response after neoadjuvant bevacizumab- or cetuximab-based chemotherapy in resected colorectal cancer liver metastases 1-lug-2015 F. PietrantonioV. MazzaferroCOTSOGLOU, CHRISTIANG. FanettiP. BiondaniC. MaggiF. de Braud + Article (author) -
Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab : a meta-analysis 1-mar-2015 F. PietrantonioK. BorgonovoC. MaggiF. De Braud + Article (author) -
Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives 1-lug-2019 Vernieri, ClaudioMennitto, AlessiaMaggi, ClaudiaPrisciandaro, MicheleFabbroni, Chiarade Braud, Filippo + Article (author) -
Role of cMET in the development and progression of colorectal cancer 1-set-2013 P. BiondaniC. MaggiF. de BraudF. Pietrantonio + Article (author) -
Role of MGMT as biomarker in colorectal cancer 16-dic-2014 G. FanettiC. MaggiF. de BraudF. Pietrantonio + Article (author) -
Single agent panitumumab in kras wild-type metastatic colorectal cancer patients following cetuximab-based regimens 1-dic-2013 F. PietrantonioP. BiondaniC. MaggiF. VenturiniG. FanettiF. De Braud + Article (author) -